A Study to Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended Users in the US
NCT07061912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122
Last updated 2025-08-20
Summary
The objective of this study is to evaluate the performance of INSTI® HIV Self Test with unobserved intended user population. The purpose of this study is to document if a lay person, unassisted by a healthcare worker, is able to perform the INSTI® HIV Self Test correctly and without significant risk of incorrect results. The study aims to evaluate the clinical performance (i.e., diagnostic sensitivity and specificity) of the INSTI® HIV Self-Test in a lay user population.
Conditions
- Human Immunodeficiency Virus I Infection
- Human Immunodeficiency Virus II Infection
Interventions
- DEVICE
-
NSTI® HIV Self-Test
Each participant will be provided with the INSTI® HIV Self-Test(s) and asked to conduct self testing, unobserved. The participant will record their interpretation of the results. Subjects will perform the test without intervention or observation from the operator. The operator will then enter the room and also interpret the subject's self-test results then perform the comparator test. In the event of a discrepant result between the INSTI® HIV ST and comparator test, an additional venous blood sample will be collected from the subject and sent for discrepancy testing
Sponsors & Collaborators
-
bioLytical Laboratories
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-24
- Primary Completion
- 2025-08-06
- Completion
- 2025-08-06
- FDA Device
- Yes
Countries
- Canada
Study Locations
More Related Trials
-
HIV-1 Vaccine Test in Uninfected Adult Volunteers
NCT00047931 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
NCT01032902 ·Status: COMPLETED
-
Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
NCT00434512 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of HIV in Newly Infected Individuals
NCT00000930 ·Status: COMPLETED
-
Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART
NCT05144386 ·Status: COMPLETED ·Phase: PHASE1
-
Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay
NCT02401555 ·Status: COMPLETED
-
Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults
NCT00043511 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
NCT00000756 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals
NCT03225118 ·Status: COMPLETED
-
Probiotic Visbiome for Inflammation and Translocation in HIV II
NCT02441231 ·Status: UNKNOWN ·Phase: PHASE2
-
Performance and Usability Evaluation of the Atomo HIV Self-Test
NCT03755986 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
NCT00672191 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
NCT04212091 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
NCT00058734 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults
NCT00141024 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers
NCT02038842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4
-
Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines
NCT00001210 ·Status: COMPLETED
-
A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
NCT00029913 ·Status: COMPLETED
-
Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052
NCT00091416 ·Status: COMPLETED ·Phase: PHASE1
-
Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
NCT01344642 ·Status: COMPLETED
-
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
NCT01790633 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3
NCT00001064 ·Status: TERMINATED ·Phase: NA
-
Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV
NCT05330143 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity of COVID-19 Vaccination in PLWH
NCT04894448 ·Status: UNKNOWN